down arrow

Wockhardt

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE049B01025
  • NSEID: WOCKPHARMA
  • BSEID: 532300
INR
1,319.45
119.95 (10.0%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.43 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,223.501,319.45

52 Week

489.201,678.60
Valuation
Technical
Day's Volume

CASH

6.43 lacs (-21.74%) Volume

Shareholding (Dec 2024)

FII

6.54%

Held by 114 FIIs

DII

9.83%

Held by 14 DIIs

Promoter

49.09%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%

  • Poor long term growth as Net Sales has grown by an annual rate of -2.63% and Operating profit at -31.36% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 17.34 times
2

With ROCE of -1.6, it has a Expensive valuation with a 3.9 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 21,439 Cr (Mid Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.62

stock-summary
Return on Equity

-8.48%

stock-summary
Price to Book

5.74

Revenue and Profits (1 Year):
Net Sales:
721 Cr
(Quarterly Results - Dec 2024)
Net Profit:
14 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
32.61%
0%
32.61%
1 Year
128.93%
0%
128.93%
2 Years
705.03%
0%
705.03%
3 Years
336.83%
0%
336.83%
4 Years
178.04%
0%
178.04%
5 Years
467.99%
0%
467.99%

Latest dividend: 10 per share ex-dividend date: Nov-17-2016

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-2.63%
EBIT Growth (5y)
-31.36%
EBIT to Interest (avg)
-0.36
Debt to EBITDA (avg)
22.48
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.51
Tax Ratio
8.62%
Dividend Payout Ratio
0
Pledged Shares
16.98%
Institutional Holding
16.38%
ROCE (avg)
-2.29%
ROE (avg)
5.58%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
5.74
EV to EBIT
5402.54
EV to EBITDA
95.62
EV to Capital Employed
3.92
EV to Sales
7.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.58%
ROE (Latest)
-8.48%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

16.9835

Mutual Funds

Held by 15 Schemes (7.13%)

FIIs

Held by 114 FIIs (6.54%)

Promoter with highest holding

Themisto Trustee Company Private Limited (40.16%)

Highest Public shareholder

Estate Of Late Mr. Rakesh Jhunjhunwala (1.75%)

Individual Investors Holdings

27.49%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -10.88% vs 9.47% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 163.64% vs -57.14% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "721.00",
          "val2": "809.00",
          "chgp": "-10.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "128.00",
          "val2": "110.00",
          "chgp": "16.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "60.00",
          "val2": "73.00",
          "chgp": "-17.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.00",
          "val2": "-22.00",
          "chgp": "163.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.75%",
          "val2": "13.60%",
          "chgp": "4.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 10.81% vs 9.65% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 82.94% vs 17.58% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,548.00",
          "val2": "1,397.00",
          "chgp": "10.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "201.00",
          "val2": "88.00",
          "chgp": "128.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "146.00",
          "val2": "155.00",
          "chgp": "-5.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-14.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-36.00",
          "val2": "-211.00",
          "chgp": "82.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.98%",
          "val2": "6.30%",
          "chgp": "6.68%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.15% vs 6.34% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 92.52% vs 16.48% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,269.00",
          "val2": "2,098.00",
          "chgp": "8.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "329.00",
          "val2": "125.00",
          "chgp": "163.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "206.00",
          "val2": "232.00",
          "chgp": "-11.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-14.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-22.00",
          "val2": "-294.00",
          "chgp": "92.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.50%",
          "val2": "5.96%",
          "chgp": "8.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 5.55% vs -17.93% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 17.17% vs -129.10% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,798.00",
          "val2": "2,651.00",
          "chgp": "5.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.00",
          "val2": "101.00",
          "chgp": "-61.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "305.00",
          "val2": "302.00",
          "chgp": "0.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.00",
          "val2": "-294.00",
          "chgp": "95.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-463.00",
          "val2": "-559.00",
          "chgp": "17.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.39%",
          "val2": "3.81%",
          "chgp": "-2.42%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
721.00
809.00
-10.88%
Operating Profit (PBDIT) excl Other Income
128.00
110.00
16.36%
Interest
60.00
73.00
-17.81%
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.00
-22.00
163.64%
Operating Profit Margin (Excl OI)
17.75%
13.60%
4.15%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -10.88% vs 9.47% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 163.64% vs -57.14% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,548.00
1,397.00
10.81%
Operating Profit (PBDIT) excl Other Income
201.00
88.00
128.41%
Interest
146.00
155.00
-5.81%
Exceptional Items
0.00
-14.00
100.00%
Consolidate Net Profit
-36.00
-211.00
82.94%
Operating Profit Margin (Excl OI)
12.98%
6.30%
6.68%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 10.81% vs 9.65% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 82.94% vs 17.58% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,269.00
2,098.00
8.15%
Operating Profit (PBDIT) excl Other Income
329.00
125.00
163.20%
Interest
206.00
232.00
-11.21%
Exceptional Items
0.00
-14.00
100.00%
Consolidate Net Profit
-22.00
-294.00
92.52%
Operating Profit Margin (Excl OI)
14.50%
5.96%
8.54%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 8.15% vs 6.34% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 92.52% vs 16.48% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2,798.00
2,651.00
5.55%
Operating Profit (PBDIT) excl Other Income
39.00
101.00
-61.39%
Interest
305.00
302.00
0.99%
Exceptional Items
-14.00
-294.00
95.24%
Consolidate Net Profit
-463.00
-559.00
17.17%
Operating Profit Margin (Excl OI)
1.39%
3.81%
-2.42%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 5.55% vs -17.93% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 17.17% vs -129.10% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Wockhardt Ltd stock-summary
stock-summary
Wockhardt Ltd
Mid Cap
Pharmaceuticals & Drugs
Wockhardt Limited, incorporated in July, 1999 is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. The Company is India's leading research-based global healthcare enterprise in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. It has 12 manufacturing locations and there are 3 locations where research and development activities are carried out.
Company Coordinates stock-summary
Company Details
D-4 MIDC, Chikalthana Aurangabad. Maharashtra : 431006
stock-summary
Tel: 91-240-6694444
stock-summary
http://www.wockhardt.com
stock-summary
investorrelations@wockhardt.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."